Literature DB >> 6870797

Similarities in the heavy and light chains of tetanus toxin suggested by their amino acid compositions.

C F Taylor, P Britton, S van Heyningen.   

Abstract

Quantitative comparison of the amino acid compositions of the heavy and light chains of tetanus toxin by the method of Cornish-Bowden [(1983) Methods Enzymol. 91, 60-75)] suggests strongly that there is sequence homology between the two chains and that the heavy chain has two similar halves. Examination (by electrophoresis in polyacrylamide gels in the presence of sodium dodecyl sulphate) of peptides produced from the chains by proteolytic cleavage supports this idea.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870797      PMCID: PMC1154173          DOI: 10.1042/bj2090897

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  9 in total

1.  Binding of ganglioside by the chains of tetanus toxin.

Authors:  S van Heyningen
Journal:  FEBS Lett       Date:  1976-09-15       Impact factor: 4.124

2.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

3.  How reliably do amino acid composition comparisons predict sequence similarities between proteins?

Authors:  A Cornish-Bowden
Journal:  J Theor Biol       Date:  1979-02-21       Impact factor: 2.691

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Solid-phase sequence analysis of polypeptides eluted from polyacrylamide gels. An aid to interpretation of DNA sequences exemplified by the Escherichia coli unc operon and bacteriophage lambda.

Authors:  J E Walker; A D Auffret; A Carne; A Gurnett; P Hanisch; D Hill; M Saraste
Journal:  Eur J Biochem       Date:  1982-04-01

6.  Structure of tetanus toxin. II. Toxin binding to ganglioside.

Authors:  T B Helting; O Zwisler; H Wiegandt
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

7.  Relating proteins by amino acid composition.

Authors:  A Cornish-Bowden
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Purification of tetanus toxin and its peptide components by preparative polyacrylamide gel electrophoresis.

Authors:  S J DiMari; M A Cumming; J H Hash; J P Robinson
Journal:  Arch Biochem Biophys       Date:  1982-03       Impact factor: 4.013

9.  Plasmid-associated toxigenicity in Clostridium tetani.

Authors:  W J Laird; W Aaronson; R P Silver; W H Habig; M C Hardegree
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

  9 in total
  6 in total

Review 1.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

2.  Failure of analysis of amino acid composition as a probe for sequence similarity in tetanus toxin.

Authors:  S van Heyningen; A F Coulson
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

3.  Enzymatic hydrolysis of tetanus toxin by intrinsic and extrinsic proteases. Characterization of the fragments by monoclonal antibodies.

Authors:  K Goretzki; E Habermann
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

4.  Antibodies against the light chain of tetanus toxin in human sera.

Authors:  C S Lin; W H Habig; M C Hardegree
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  The amino acid compositions of proteins are correlated with their molecular sizes.

Authors:  A Cornish-Bowden
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

6.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.